In ovo administration of CpG oligodeoxynucleotides and the recombinant microneme protein MIC2 protects against Eimeria infections
- 2 May 2005
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 23 (24), 3108-3113
- https://doi.org/10.1016/j.vaccine.2005.01.073
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- EMBRYO VACCINATION AGAINST EIMERIA TENELLA AND E. ACERVULINA INFECTIONS USING RECOMBINANT PROTEINS AND CYTOKINE ADJUVANTSJournal of Parasitology, 2005
- In VivoEffects of CpG Oligodeoxynucleotide on Eimeria Infection in ChickensAvian Diseases, 2004
- Immunotherapeutic uses of CpG oligodeoxynucleotidesNature Reviews Immunology, 2004
- Intestinal Immunomodulation by Vitamin A Deficiency and Lactobacillus-Based Probiotic in Eimeria acervulina–Infected Broiler ChickensAvian Diseases, 2003
- Vaccination with Novel Immunostimulatory Adjuvants against Blood-Stage Malaria in MiceInfection and Immunity, 2003
- Protection of Chickens againstEscherichia coliInfections by DNA Containing CpG MotifsInfection and Immunity, 2003
- CpG Motifs in Bacterial DNA and Their Immune EffectsAnnual Review of Immunology, 2002
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- Embryo vaccination of turkeys against Newcastle disease infection with recombinant fowlpox virus constructs containing interferons as adjuvantsVaccine, 1999
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995